-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Vistagen Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q2 2021 to Q2 2023.
- Vistagen Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $223K, a 8.83% increase year-over-year.
- Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $700K, a 22.2% decline from 2022.
- Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $900K, a 6.6% increase from 2021.
- Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $844K, a 6.66% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)